isosorbide mononitrate 30 mg

INDICATIONS AND USAGE Isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Golden State Medical Supply, Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] nausea` `[3] fatigue` `[4] off label use` `[5] diarrhoea` `[6] dyspnoea` `[7] pain` `[8] headache` `[9] vomiting` `[10] dizziness`

1 year ago

OVAL WHITE ING 175

HOW SUPPLIED

ISOSORBIDE MONONITRATE Extended-Release Tablets USP, 30 mg are white to off-white, uncoated, oval shaped tablets debossed with 'ING 175' one side and scored on the other side. They are supplied as follows: Bottles of 100 NDC 51407-208-01 Bottles of 500 NDC 51407-208-05

ISOSORBIDE MONONITRATE Extended-Release Tablets USP, 60 mg are white to off-white, uncoated, capsule shaped tablets debossed with 'ING 176' one side and scored on the other side. They are supplied as follows: Bottles of 100 NDC 51407-209-01 Bottles of 500 NDC 51407-209-05

ISOSORBIDE MONONITRATE Extended-Release Tablets USP, 120 mg are white to off-white, uncoated, oval shaped tablets debossed with 'ING 177' one side and plain on the other side. They are supplied as follows: Bottles of 100 NDC 51407-210-01 Store at 20 o -30 o C (68 o -86 o F) [See USP Controlled Room Temperature]. Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32811-7193 Made in India DRUGS/TS/23/2007 Rev.: 09/2023 Marketed by: GSMS, Inc. Camarillo, CA 93012 USA Ingenus logo

More pills like OVAL ING 175

Related Pills

isosorbide mononitrate 60 mg

Golden State Medical Supply, Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site